Non-adherence and graft failure in adult liver transplant recipients

Digestive Diseases and Sciences

Volumn 58, Issue 3, 2013, Pages 824-834

  Lieber, Sarah R ^a   Volk, Michael L ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Adherence; Compliance; Graft failure; Liver transplantation

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; DISEASE SEVERITY; EMPLOYMENT STATUS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOCIAL STATUS; SOCIAL SUPPORT; SUBSTANCE ABUSE; TREATMENT OUTCOME; UNEMPLOYMENT;

COHORT STUDIES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SOCIAL SUPPORT; TACROLIMUS;

EID: 84876674795     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2412-0     Document Type: Article

References (33)

1. Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Trans Proc. 2007;39:3169-3174.
2. Volk M. Personal communication. In: Lieber S, ed. City; 2010.
3. Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clinic Proc. 2008;83:165-168.
4. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59:13-20.
5. Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Trans Int. 2005;18:1121-1133.
6. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858-873.
7. Lisson GL, Rodrigue JR, Reed AI, Nelson DR. A brief psychological intervention to improve adherence following transplantation. Ann Trans. 2005;10:52-57.
8. Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Trans. 2004;8:233-236.
9. Stuber ML, Shemesh E, Seacord D, Washington J III, Hellemann G, McDiarmid S. Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Trans. 2008;12:284-288.
10. Venkat VL, Nick TG, Bucuvalas JC, Wang Y. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Trans. 2008;12:67-72.
11. Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113:825-832.
12. Morales JM, Varo E, Lazaro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transpl. 2012;26:369-376.
13. Drent G, Haagsma EB, Geest SD, et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transpl Int. 2005;18:960-966.
14. Lamba S, Nagurka R, Desai KK, Chun SJ, Holland B, Koneru B. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transpl. 2012;26:328-335.
15. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transpl. 2009;9:35-41.
16. Osterberg L, Blaschke T. Drug therapy - adherence to medication. N Engl J Med. 2005;353:487-497.
17. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497-1504.
18. Chisholm MA. Enhancing transplant patients' adherence to medication therapy. Clin Transpl. 2002;16:30-38.
19. Drent G, De Geest S, Haagsma EB. Prednisolone noncompliance and outcome in liver transplant recipients. Transpl Int. 2006;19:342-343.
20. Telles-Correia D, Barbosa A, Mega I, Monteiro E. Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal. Prog Transpl. 2012;22:91-94.
21. Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93:958-963.
22. Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159-172.
23. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426.
24. O'Carroll RE, McGregor LM, Swanson V, Masterton G, Hayes PC. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl. 2006;12:1862-1868.
25. Medical Outcomes Study Social Support Survey (MOSSS). Available at: http://www.rand.org/health/surveys-tools/mos/mos-socialsupport.html. Accessed 7/2010
26. Sherbourne CD SA. The MOS social support survey. Soc Sci Med. 1991;32:705-714.
27. Telles-Correia D, Barbosa A, Mega I, Monteiro E. Adherence correlates in liver transplant candidates. Transpl Proc. 2009;41:1731-1734.
28. Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transpl. 2008;8:616-626.
29. Beckebaum S, Iacob S, Sweid D, et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666-675.
30. Dharancy S, Giral M, Tetaz R, Fatras M, Dubel L, Pageaux GP. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin Transpl. 2012;26:E293-E299.
31. Merli M, Di Menna S, Giusto M, et al. Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. Transpl Proc. 2010;42:1322-1324.
32. Stilley CS, DiMartini AF, de Vera ME, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transpl. 2010;20:58-66; quiz 67.
33. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22:780-797.